Baculoviral IAP Repeat-Containing Protein 7 (BIRC7) Antibody

Product Graph
260€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Baculoviral IAP Repeat-Containing Protein 7 (BIRC7) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx456792
tested applications
ELISA, WB, IHC

Description

Baculoviral IAP Repeat-Containing Protein 7 (BIRC7) Antibody is a Rabbit polyclonal antibody for the detection of Human Baculoviral IAP Repeat-Containing Protein 7 (BIRC7).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Baculoviral IAP Repeat-Containing Protein 7 (BIRC7)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Size 1
50 µg
Size 2
100 µg
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
0.01 M PBS, pH 7.4, 50% glycerol, 0.05% Proclin-300.
Availability
Shipped within 5-12 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q96CA5
Gene ID
79444
NCBI Accession
NP_071444.1
Background
Antibody anti-BIRC7
Status
RUO

Descripción

Related Products

EH2704

Human BIRC7 (Baculoviral IAP repeat-containing protein 7) ELISA Kit

Ver Producto
P8944

Recombinant Human BIRC7

Ver Producto
abx004387

Baculoviral IAP Repeat Containing Protein 7 (BIRC7) Antibody

BIRC7 Antibody is a Rabbit Polyclonal antibody against BIRC7. This gene encodes a member of the inhibitor of apoptosis protein (IAP) family, and contains a single copy of a baculovirus IAP repeat (BIR) as well as a RING-type zinc finger domain. The BIR domain is essential for inhibitory activity and interacts with caspases, while the RING finger domain sometimes enhances antiapoptotic activity but does not inhibit apoptosis alone. Elevated levels of the encoded protein may be associated with cancer progression and play a role in chemotherapy sensitivity. Alternative splicing results in multiple transcript variants.

Ver Producto